Minnesota startup Embomedics is developing resorbable transarterial chemoembolization microspheres (that’s a mouthful), and is in the midst of a $5 million equity raise to bring ’em to fruition, according to a regulatory filing. In essence, it has created biodegradable hollow beads that can deliver drugs to a localized tumor site, and additionally block off blood flow to the area […]
EmboMedics, a Maple Grove, Minn.-based medical device company, has raised $860,000 in equity, according to a regulatory filing made with the SEC. The Series A funding will go mainly toward research and development of its resorbable embolization material, Omid Souresrafil, EmboMedics CEO and co-founder, said. He said the money should take the company through the […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.